Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer's disease. Find out how to enroll.
Read more »
Sunday, December 23, 2012
Merck's EPOCH Clinical Trial for Alzheimer's Enrolling 1,700 People
Labels:
Clinical Trials •
Research